UpGuard's Cyber Security Ratings range from 0 to 950. The higher the score, the more likely CohBar is implementing good security practices.
CohBar, Inc. is a leader in the research and development of mitochondria based therapeutics (MBTs), an emerging class of drugs with the potential to treat a wide range of diseases associated with aging and metabolic dysfunction including non-alcoholic steatohepatitis (NASH), obesity, Type 2 diabetes (T2D), cancer, cardiovascular disease and CNS disorders.
This report shows a preliminary security rating for CohBar. UpGuard scans billions of digital assets daily, in depth, across thousands of vectors. Data leak detection, vulnerability scanning and identity breach detection are just some of the advanced capabilities offered by the UpGuard platform.Get a deeper scan →
Read more about the latest issues in cybersecurity
A cyber attack (or cyberattack) is any attempt to expose, alter, disable, destroy, steal or gain ...
Vendor risk management (VRM) deals with the management and monitoring of risks resulting from ...
Compare CohBar's security performance with other companies